KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Price (Quote)

$1.23
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $1.23 $1.23 Friday, 27th May 2022 CTRV stock ended at $1.23. During the day the stock fluctuated 0% from a day low at $1.23 to a day high of $1.23.
90 days $0.94 $1.27
52 weeks $0.86 $2.32

Historical ContraVir Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jun 07, 2019 $6.86 $11.02 $6.50 $7.98 4 932 485
Jun 06, 2019 $12.85 $15.75 $7.01 $7.08 7 824 717
Jun 05, 2019 $5.33 $5.33 $4.80 $5.00 140 529
Jun 04, 2019 $5.64 $6.44 $5.11 $5.54 245 082
Jun 03, 2019 $7.43 $8.68 $5.31 $5.60 447 245
May 31, 2019 $0.108 $0.117 $0.104 $0.107 7 014 795
May 30, 2019 $0.119 $0.129 $0.115 $0.120 1 855 270
May 29, 2019 $0.121 $0.125 $0.112 $0.122 2 952 003
May 28, 2019 $0.120 $0.125 $0.115 $0.118 2 046 015
May 24, 2019 $0.123 $0.135 $0.112 $0.112 3 740 227
May 23, 2019 $0.110 $0.140 $0.110 $0.131 11 418 142
May 22, 2019 $0.115 $0.115 $0.109 $0.110 2 267 598
May 21, 2019 $0.116 $0.122 $0.108 $0.115 2 008 990
May 20, 2019 $0.124 $0.124 $0.110 $0.118 3 099 100
May 17, 2019 $0.127 $0.127 $0.115 $0.117 1 966 936
May 16, 2019 $0.130 $0.130 $0.110 $0.121 3 161 876
May 15, 2019 $0.129 $0.132 $0.123 $0.125 2 341 456
May 14, 2019 $0.128 $0.137 $0.120 $0.128 3 258 574
May 13, 2019 $0.126 $0.133 $0.124 $0.128 2 277 589
May 10, 2019 $0.136 $0.138 $0.126 $0.128 3 426 468
May 09, 2019 $0.130 $0.157 $0.125 $0.138 7 668 506
May 08, 2019 $0.141 $0.143 $0.125 $0.128 5 048 144
May 07, 2019 $0.144 $0.146 $0.134 $0.139 4 003 326
May 06, 2019 $0.150 $0.155 $0.141 $0.147 4 546 456
May 03, 2019 $0.165 $0.165 $0.141 $0.147 6 686 792
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT